The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2023

Filed:

Apr. 13, 2020
Applicant:

Aston University, Birmingham, GB;

Inventors:

Meng Cai, Birmingham, GB;

Keqinq Wang, Birmingham, GB;

Asif Ahmed, Birmingham, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/713 (2006.01); C12N 15/11 (2006.01); C12Q 1/6883 (2018.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 31/713 (2013.01); C12N 15/111 (2013.01); C12Q 1/6883 (2013.01); G01N 33/50 (2013.01); C12N 2310/113 (2013.01); C12N 2310/141 (2013.01); C12N 2320/30 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/178 (2013.01);
Abstract

The invention provides a method of treating preeclampsia, fetal growth restriction (FGR or IUGR), obesity in pregnancy, post-partum cardiomyopathy (heart failure in mothers), cancer and diabetic retinopathy, cardiomyopathy, myocardial infarction, wet microdegeneration and other disorders where angiogenesis is aberrant either diminished or exacerbated, comprising modulating the activity of micro RNA (miRNA). Also provided are an MiRNA modulator or a combination thereof or functional fragments or homologues thereof for use in the treatment of preeclampsia, fetal growth restriction, obesity in pregnancy, cancer, and diabetic retinopathy, cardiomyocyte infarction, wet microdegeneration as well as other disorder where angiogenesis is aberrant either diminished or exacerbated. Methods of modulating angiogenesis and pharmaceutical compositions using miR-122, miR-374b or inhibitors of miR-152 or miR195 are also provided together with methods of diagnosis using the miRNAs.


Find Patent Forward Citations

Loading…